News Daily News Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina Michael O'Riordan June 30, 2016
News Daily News Precious Time: Questionable Treatments Often Used at the End of Life Todd Neale June 30, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care Michael O'Riordan June 29, 2016
News Daily News CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso L.A. McKeown June 29, 2016
News Daily News CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease L.A. McKeown June 29, 2016
News Daily News Don’t Dismiss Diabetes: Long-Term Mortality After Acute MI Linked With the Disease in Large Population Study Yael L. Maxwell June 29, 2016
News Features Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding Yael L. Maxwell June 29, 2016